Trials / Completed
CompletedNCT02125825
Ambulatory Parkinson's Disease Dyskinesia Monitor for Drug Therapy Titration
Kinesia-D Phase II In-Clinic Continuous Assessment Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 14 (actual)
- Sponsor
- Great Lakes NeuroTechnologies Inc. · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The objective is to assess a compact, portable, wireless movement disorder system with continuous monitoring capabilities to detect and quantify the severity of levodopa-induced dyskinesia in Parkinson's disease.
Conditions
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2014-04-29
- Last updated
- 2016-01-12
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02125825. Inclusion in this directory is not an endorsement.